Prelude Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Prelude Capital Management’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-131,260	Closed	-$1.37M	–	1484
2023 Q1	$1.37M	Buy	+131,260	New	+$1.36M	0.08%	270

Prelude Capital Management's LVAC Position: Q2 2023 in Review

Prelude Capital Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 131,260 shares — an estimated $1.37M sold.

Prelude Capital Management first reported a position in LVAC in Q1 2023 and held it in 1 quarter. The position peaked at $1.37M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Prelude Capital Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Prelude Capital Management sold 131,260 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $1.37M.
Prelude Capital Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2023 and held it in 1 quarter.
Prelude Capital Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $1.37M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.